Novavax Inc. NVAX, -21.11% The company said on Friday that it believes that “there is not enough evidence to establish a causal relationship” between COVID-19 vaccine...
Increasing concerns about the emergence of monkeypox in the West have caused stocks of several vaccine and pharmaceutical companies to skyrocket. Infections are rarely reported outside...
Lucira Health Inc. LHDX, + 0.40% On Thursday, it said it applied for approval from the Food and Drug Administration for the first COVID-19 of its...
Washington — US regulators on Thursday severely restricted who could be vaccinated with Johnson & Johnson’s COVID-19 vaccine due to the rare but serious risk of...
The Omicron variant of coronavirus, which has swept the United States since the end of last year, has suffered less damage than previous variants, including those...
Given the wise nature of SARS-CoV-2, it may not be possible to reach herd immunity. Federal health officials say the goal instead is to figure out...
Recent Comments